Safety Study of Stemchymal® in Acute Liver Failure

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05985863` - Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure	Phase 1/Phase 2
Not yet recruiting	`NCT04822922` - Safety of UC-MSC Transfusion for ACLF Patients	Phase 2
Recruiting	`NCT04578301` - Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Completed	`NCT04983108` - Utility of Liver and Splenic Stiffness in Predicting Esophageal Varices in Patients With Acute on Chronic Liver Failure
Withdrawn	`NCT05940610` - The Safety and Efficacy of MSC-EVs in Acute/Acute-on-Chronic Liver Failure	Phase 1/Phase 2
Not yet recruiting	`NCT05036031` - Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study
Recruiting	`NCT05019352` - Cytokine Adsorption in Acute-on-chronic Liver Failure	N/A
Recruiting	`NCT05421351` - Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
Completed	`NCT02321371` - Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.	N/A
Not yet recruiting	`NCT06069037` - SALT for Treatment of Patients With Early ACLF	N/A
Completed	`NCT02965560` - Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure
Recruiting	`NCT03713489` - Platelet Transfusion in HBV-related acute-on Chronic Liver Failure	N/A
Recruiting	`NCT04621812` - Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year.
Recruiting	`NCT04157465` - Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients	N/A
Suspended	`NCT03737448` - TRimetazidine for acUte on Chronic Liver Failure STudy	Phase 1
Recruiting	`NCT06128421` - Individual Nutrition Support in HBV-ACLF Patients at Nutrition Risk	N/A
Recruiting	`NCT05700708` - Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
Completed	`NCT04238416` - Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF	Phase 1
Completed	`NCT03456518` - Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver Disease
Recruiting	`NCT03987893` - PEG3350 in ACLF With Hepatic Encephalopathy	Phase 4

NCT number	NCT03629015
Study type	Interventional
Source	Steminent Biotherapeutics Inc.
Contact
Status	Withdrawn
Phase	Phase 1
Start date	October 1, 2018
Completion date	May 18, 2020

Safety Study of Stemchymal® in Acute Liver Failure — ALF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms